Application 202163
- Type
- ANDA
- Sponsor
- BRECKENRIDGE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 5MG BASE/100ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42023-163 | Zoledronic Acid | Zoledronic Acid | Par Pharmaceutical Companies, Inc. | ANDA | Current |
| 51991-064 | Zoledronic Acid | Zoledronic Acid | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-064 | Zoledronic Acid | Zoledronic Acid | Breckenridge Pharmaceutical, Inc | ANDA | Current |